Laminin chains: diagnostic uses

Chemistry: analytical and immunological testing – Involving diffusion or migration of antigen or antibody

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S001200, C435S007100, C435S007200, C435S007800, C435S009000, C435S029000, C435S040510, C435S040520, C435S325000, C435S326000, C435S330000, C435S332000, C435S344100, C435S371000, C435S375000, C435S173900, C424S574000

Reexamination Certificate

active

06955924

ABSTRACT:
The instant invention provides for the identification, diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto.

REFERENCES:
patent: 6294356 (2001-09-01), Jones et al.
patent: WO 00/26342 (2000-05-01), None
patent: WO 00/34441 (2000-06-01), None
patent: WO 01/87239 (2001-11-01), None
Giannelli et al. 1997. Science. vol. 277: 225-228.
Seaver. 1994. Genetic Engineering. 14(14):10 and 21.
Aberdam et al., (1994), Nature Genetics, “Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMANIN-5)”, vol: 6: pp. 299-304.
Amano, et al., (2000), The Journal of Biological Chemistry, “Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain”, vol: 275(30), pp. 22728-22735.
Anderson, et al., (2001), The Laryngoscope, “Tumor deposition of laminin-5 and the relationship with perineural invasion”, vol: 111, pp. 2140-2143.
Calaluce, et al., (2001), Molecular Carcinogenesis, “Laminin-5-mediated gene expression in human prostate carcinoma cells”, vol: 30, pp. 119-129.
Davis, et al., (2001), The Prostate, “Unique expression pattern of the α6β4 integrin and Laminin-5 in human prostate carcinoma”, vol: 46, pp. 240-248.
Engvall, et al., (1990), Cell Regulation, “Distribution and isolateion of four laminin variants; tissue restricted distribution of heterotrimers assembled from five subunits”, vol: 1, pp. 731-740.
Fukushima, et al., (2001), Mod. Pathol., “Expression of laminin-5-γ-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas”, vol: 14(5), pp. 404-409.
Gianelli, et al., (1997), Science, “Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5”, vol: 277, pp. 225-228.
Gianelli and Antonaci, (2001), Clinical and Experimental Metastasis, “Biological and Clinical Relevance of Laminin-5 in Cancer”, vol: 18, 439-443.
Goldfinger, et al., (1998), J. Cell Biol., “Processing of Laminin-5 and its functional consequences: Role of Plasmin and Tissue-type Plaminogen Activator”, vol: 141, pp. 255-265.
Gonzales, et al., (1999), Mol. Biol. of the Cell, “A cell signal pathway involving laminin-5, α3β1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation”, vol: 10, pp. 259-270.
Grassi, et al., (1999), Journal of Cell Science, “The SFL activity secreted by metastatic carcinoma cells is related to laminin 5 and mediates cell scattering in an integrin-independent manner”, vol: 112, pp. 2511-2520.
Haas, et al., (2001), The Journal of Histochemistry & Cytochemistry, “A comparative quantitative analysis of laminin-5 in the basement membrane of normal, hyperplastic, and malignant oral mucosa by confocal immunofluorescence imaging”, vol: 49(10), pp. 1261-1268.
Habermann, et al., (2001), Scand J. Gastroenterol, “Ulcerative colitis and colorectal carcinoma”, vol: 7, pp. 751-758.
Hao, et al., (1996), American Journal of Pathology, “Differential expression of laminin 5 (α3β3γ2) by human malignant and normal prostate”, vol: 149(4):, pp. 1341-1349.
Heagerty, et al., (1986), Lancet, “GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa”, vol: 860, p. 8485.
Heagerty, et al., (1987), British J. Dermatol, “Raid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody”, vol: 17, pp. 271-275.
Hellman, et al., (2000), Int. J. Gynecol. Cancer., “Cancer of the vagina: Laminin-5γ2 chain expression and prognosis”, vol: 10, pp. 391-396.
Henning, et al., (1999), Histopathology, “Loss of laminin-5 in the epithelium-stroma interface: an immunohistochemical marker of malignancy in epithelial lesions of the breast”, vol: 34, pp. 305-309.
Hlubek, et al., (2001), Cancer Research, “Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin1”, vol: 61, pp. 8089-8093.
Hsi, et al., (1986), J. Reprod. Immunology, “Monoclonal antibodies to human amnion”, vol: 9, pp. 11-21.
Kagesato, et al., (2001), Japan J. Cancer Research, “Sole expression of laminin γ2 chain in invading tumor cells and its associateion with stromal fibrosis in lung adenocarcinomas”, vol: 21, pp. 184-192.
Katoh, et al., (2002), Oncology, Correlation between laminin-5 γ2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue, vol: 62, pp. 318-326.
Kallunki, et al., (1992), J. Cell Biol., “A truncated laminin chain homologous to the B2 chain: Structuree, spatial expression, and chromosomal assignment”, vol: 118, pp. 679-693.
Koshikawa, et al., (1999), Cancer Research, Overexpression of laminin γ2 chain monomer in invading gastric carcinoma cells, vol: 59, pp. 5596-5601.
Lenander, et al., (2001), Analytical Cellular Pathology,“Laminin-5 γ2 chain expression correlates with unfavorable prognosis in colon carcinomas”, vol: 22, pp. 201-209.
Lohi, et al., (2000), APMIS, “Basement membrane laminin-5 is deposited in colorectal adenomas and carcinomas and serves as a ligand for α3β1 integrin”, vol: 108, pp. 161-172.
Lugassy, et al., (1999), J. Cutaneuous Pathol., “Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis”, vol: 26, pp. 222-226.
Määttä, et al., (2001), The Journal of Histochemistry & Cytochemistry, “Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the α1 chain of laminin shows a selected expression pattern in human carcinomas”, vol: 49(6), pp. 711-725.
Määttä, et al., (1999), Journal of Pathology, “Expression of the laminin γ2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization”, vol: 188, pp. 361-368.
Manda, et al., (2000), Biochemical and Biophysical Research Communications, “Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas”, vol: 275, pp. 440-445.
Marinkovich, et al., (1992), JBC, “The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor”, vol: 267, pp. 17900-17906.
Martin, et al., (1998), Mol. Med., “Down-regulation of laminin-5 in breast carcinoma cells”, vol: 4(9), pp. 601-613.
Matsui, et al., (1995), J. Invest. Dermatology, “γ2 chain of Laminin-5 is recognized by Monoclonal Antibody GB3”, vol: 105, pp. 648-652.
Matsui, et al., (1995), JBC, “The Assembly of Laminin-5 Subunits”, vol: 270(40), pp. 23496-23503.
McMillan, et al., (1997), Br. J. Dermatol., “Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation”, vol: 136, pp. 817-822.
Mizushima, et al., (1998), Horm. Res., “Wide Distribution of Laminin-5 γchain in basement membranes of various human tissues”, vol: 50 (Suppl. 2), pp. 7-14.
Mizushima, et al., (1996), J. Biochem., “Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors”, vol: 120, pp. 1196-1202.
Moriya, et al., (2001), Cancer, “Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size”, vol: 19(6), pp. 1129-1141.
Niki, et al., (2002), American Journal of Pathology, “Frequent c

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Laminin chains: diagnostic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Laminin chains: diagnostic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Laminin chains: diagnostic uses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3449138

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.